Literature DB >> 2980762

Narcotic dependence in inflammatory bowel disease.

M A Kaplan1, B I Korelitz.   

Abstract

Thirteen of 43 patients (30%) with inflammatory bowel disease referred for psychiatric consultation were found to be drug dependent, most commonly on oral narcotics. Drug dependence was more frequent in patients with Crohn's disease than ulcerative colitis and many had a borderline personality disorder. The study suggests that drug dependence is not recognized often enough in patients with inflammatory bowel disease and that patients with certain psychiatric disorders are at higher risk of developing it. Recognition of drug dependence is aided by interviewing family members. It is best prevented by seeking and treating the specific cause of pain and by having only one physician assigned to prescribe and manage narcotics.

Entities:  

Mesh:

Year:  1988        PMID: 2980762     DOI: 10.1097/00004836-198806000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  14 in total

Review 1.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

2.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Authors:  Millie D Long; Edward L Barnes; Hans H Herfarth; Douglas A Drossman
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

Review 3.  Physical and social pains in borderline disorder and neuroanatomical correlates: a systematic review.

Authors:  Déborah Ducasse; Philippe Courtet; Emilie Olié
Journal:  Curr Psychiatry Rep       Date:  2014-05       Impact factor: 5.285

Review 4.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

5.  Inflammatory bowel disease in children: psychological and psychiatric issues.

Authors:  Parikshit Deshmukh; Gaurav Kulkarni; Jeanne Lackamp
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

6.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

7.  Borderline personality and the pain paradox.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2007-04

8.  Polysubstance use in inflammatory bowel disease.

Authors:  Kaleb Bogale; Kent Vrana; Wesley Raup- Konsavage; Vonn Walter; August Stuart; Shannon Dalessio; Walter Koltun; Nana Bernasko; Andrew Tinsley; Emmanuelle Williams; Kofi Clarke; Matthew D Coates
Journal:  J Dig Dis       Date:  2021-11-28       Impact factor: 2.325

9.  Clinical markers of Crohn's disease severity and their association with opiate use.

Authors:  Mary Cheung; Sundas Khan; Meredith Akerman; Chun Kit Hung; Kaitlyn Vennard; Nicholas Hristis; Keith Sultan
Journal:  J Clin Med Res       Date:  2014-10-16

10.  Analysis of the clinical indications for opiate use in inflammatory bowel disease.

Authors:  Youran Gao; Sundas Khan; Meredith Akerman; Keith Sultan
Journal:  Intest Res       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.